NEPHROPLUS in Focus: Nephrocare Health Serv Share Price Opens Gap-Down at ₹733.10 on Rising Newsflow
Quick answer
Nephrocare Health Serv (NEPHROPLUS) trades at ₹747.25, +13.80 (+1.85%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Generated from exchange and market-data feeds by the TrendRipperX Data Desk. Prices can be delayed; this report describes price moves and does not claim to know why a stock moved.

Quick summary
Last price
₹747.25
+1.85%
Day range
₹731.05 – ₹751.15
52-week high
₹770
Nephrocare Health Serv share price today, and the reason behind it
Shares of Nephrocare Health Serv are changing hands at ₹747.25 on the NSE board as of 12:05 am IST on 11 September 2026 — +13.80 or +1.85% from the previous close of ₹747.25. Behind the number, the session opened below the previous close, and gaps that are not filled in the first hour usually take the rest of the day to repair.
Highlights
- Where it trades: Nephrocare Health Serv is at ₹747.25, +13.80 (+1.85%) versus the previous close of ₹747.25.
- Why it is moving: an in-focus story — one business desk filed on the company in the last few hours.
- Today's band: ₹731.05 to ₹751.15, against an open of ₹733.10 — the stock is defending its opening print.
- Twelve-month context: 2.92% below the ₹770 high and 67.54% above the ₹446 low, so the stock sits in the upper part of its own range.
- Participation: turnover is running at 1.0x the twenty-day average, which is ordinary flow — the move lacks a volume endorsement so far.
- What to watch: an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two.
Why Nephrocare Health Serv is on the desks today
Nephrocare Health Serv is one of the most-mentioned names on the business wires right now — reported by one desk so far, with the headlines linked below. When several desks run the same company on the same day, the flow that follows is usually driven by attention rather than by a single disclosure, so the price move needs volume behind it to mean anything.
The board at a glance
| Field | Value |
|---|---|
| Last price | ₹747.25 |
| Change | +13.80 (+1.85%) |
| Open | ₹733.10 |
| Day range | ₹731.05 – ₹751.15 |
| Previous close | ₹747.25 |
| Volume | 2,04,920 |
| 52-week range | ₹446 – ₹770 |
| 20-day average volume | 2,10,147 |
How the session has traded
Nephrocare Health Serv has traded between ₹731.05 and ₹751.15 in this session against an open of ₹733.10 and a previous close of ₹747.25. That is a band of ₹20.10, or 2.69% of the current price — an ordinary day's spread, so the move is orderly rather than disorderly.
Holding above the open at ₹733.10 matters because it is the level intraday desks use as the session pivot: buyers who entered at the open are in profit, so there is no forced supply from that cohort.
In market-structure terms this is a continuation session, so the prior trend remains the base case until a level breaks.
What it means when several desks run the same name
A publisher filed on Nephrocare Health Serv in the last few hours without a single dominant disclosure driving it. Clustered coverage of this kind is usually attention rather than information: a screen result, a sector read-across, or a follow-up to something filed earlier in the week. Attention brings order flow, but order flow without a disclosure behind it decays.
The way to separate the two is participation. A move on turnover at or above the stock's own recent average means positions are changing hands and the level is likely to hold. The same move on thin volume is a handful of trades and reverses easily, which is why the volume column deserves as much attention as the percentage change.
Nephrocare Health Serv is at ₹747.25, +13.80 (+1.85%), between ₹731.05 and ₹751.15 on the day, on 1.0x its twenty-day average volume.
The longer-horizon picture
| Period | Return |
|---|---|
| 1W | +7.87% |
| 1M | +4.91% |
| 3M | -0.54% |
| 6M | +32.53% |
| 1Y | +58.57% |
What the returns table is saying
Over the last week Nephrocare Health Serv has gained +7.87% and over the month +4.91%. Both horizons pointing the same way means the recent move is an extension of the existing trend rather than a reversal.
The twelve-month return of +58.57% is the context long-term holders judge the stock on. After a run of this size, most of the easy re-rating is behind the price, so incremental gains usually have to come from delivered earnings rather than sentiment.
Reading the price against its own ranges
Over the last twelve months the price has covered ₹446 to ₹770. The current level is 93% of the way through that band, 2.92% below the 52-week high and 67.54% above the 52-week low. Trading this close to the yearly high means there is little overhead supply from earlier buyers, which is why breakouts here tend to extend — but it also leaves no cushion if the news flow turns.
Traded quantity of 2,04,920 shares is 0.98x the 20-day average of 2,10,147. Turnover close to the recent norm suggests an orderly session rather than a scramble, so the move reflects ordinary two-way flow.
What the newswires are reporting
Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.
What decides the next session
For this in focus story specifically, watch an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two. On the chart, the ₹751.15 high and ₹731.05 low of this session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of today's low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 2,10,147 shares to be read as positioning rather than a squeeze.
How to read this as an investor
For a trader, this is a low-information session: the move sits inside the stock's normal daily spread, so there is no edge in chasing it. Waiting for a close outside ₹731.05–₹751.15 is the cheaper way to be positioned.
For a long-term shareholder, one session tells you very little. The stock is 2.92% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.
On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.
In summary
Nephrocare Health Serv is being bought on an in-focus story, and at ₹747.25 the move is not yet backed by turnover above its own average, which is the version of a rally that tends to fade. The day's ₹731.05–₹751.15 band is the frame for the next session, and an exchange filing from the company itself is what resolves the story either way.
Where to track NEPHROPLUS next
Live price, charts and technicals stay on the Nephrocare Health Serv stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.
Frequently asked questions
What is the Nephrocare Health Serv share price today?
Nephrocare Health Serv (NEPHROPLUS) last traded at ₹747.25, +13.80 (+1.85%) against the previous close of ₹747.25, read from the NSE board at 12:05 am IST on 11 September 2026.
Why is Nephrocare Health Serv in the news today?
1 business publisher ran headlines on the company in the last session — a in focus story. Their reports are linked above; the levels and tables here are read independently from exchange data.
What is the 52-week high and low of NEPHROPLUS?
Over the last twelve months NEPHROPLUS has traded between a low of ₹446 and a high of ₹770, computed from the adjusted daily series.
Is NEPHROPLUS up or down today?
NEPHROPLUS gained +1.85% in this session, trading between ₹731.05 and ₹751.15 against an open of ₹733.10.
Key takeaways
- Last price: ₹747.25 (+1.85%) — higher at the time of writing
- Day range: ₹731.05 – ₹751.15
- 52-week high: ₹770
About this report
Every figure on this page is read from a primary source at the timestamp shown — exchange boards for equities and indices, the exchange bid book for IPOs, published association rates for bullion, and consolidated exchange quotes for crypto — with no estimation or third-party commentary. Historical fields such as trailing returns and 52-week extremes are computed on the adjusted daily series so splits and bonuses do not create false gaps. A timestamp outside market hours reflects the last traded or last published value, not a live tick.
Related live pages
Sources
- NSE live board data via our exchange data feed
- Headline attribution links above point to the original publishers
- TrendRipperX Nephrocare Health Serv stock page
“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”
Comments
Comments are moderated. Be civil, no stock tips or promotions.
Loading comments…
Written by TrendRipperX Data Desk. Figures come from exchange, company and market-data sources linked in the story. Spotted an error? Tell the newsroom — see our corrections policy and editorial policy.
For information only, not investment advice. TrendRipperX is not a SEBI-registered adviser. Full disclaimer.
Related articles

Laurus Labs Share Price Hit 52-Week High, Up 4.51% on Brokerage Call News — What It Means for Investors
Laurus Labs (LAURUSLABS) last traded at ₹2,058.90, +88.90 (+4.51%). The brokerage-call trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.

Anand Rathi Wealth Share Price Edges Lower to ₹2,222.40 Today — Volumes, 52-Week Range and What to Watch Next
Anand Rathi Wealth (ANANDRATHI) trades at ₹2,222.40, -12.60 (-0.56%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.

THELEELA in Focus: Leela Palaces Hotel Share Price Dropped 3.21% to ₹576.50 in the News Today
Leela Palaces Hotel (THELEELA) last traded at ₹576.50, -19.15 (-3.21%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Newsletter

